Form 4 Filing for Fulgent Genetics, Inc. - Officer Transaction

This filing reports a transaction by Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc. On April 26, 2026, Mr. Kim disposed of 2,747 shares of Common Stock at a price of $16.31 per share. These shares were withheld to cover tax obligations arising from the vesting of restricted stock units, as detailed in a previous Form 4 filing from November 9, 2022, related to a merger agreement. Following this transaction, Mr. Kim directly owns 365,800 shares of Fulgent Genetics, Inc. common stock.